Zuzana Santamaria, Project Manager at European Society of Gynecological Oncology, shared a post on LinkedIn:
“What are GLP-1 receptor agonists? And are they a magic bullet?
GLP-1 receptor agonists are important because they represent a major shift in how medicine treats metabolism, obesity, and chronic disease.
In the European Society of Gynaecological Oncology, we focus on GLP-1’s impact on gynaecological cancers. In this webinar, we will go beyond cancer and tackle the psychogenic effects of GLP-1 receptor agonists, including impacts on mood and appetite regulation.
This topic is timely not only for gynae-oncologists. Thanks to the scientific lead of this webinar, Elmar Joura, you may look forward to:
- What are GLP-1 Agonists with Clemens Tempfer
- GLP-1 Receptor Agonists and Endometrial Cancer with Magdalena Postl
- GLP-1 Receptor Agonists and Breast Cancer with George Pfeiler
- GLP1-Receptor Agonists and Psychiatric Disorders with Clemens Tempfer
Register.”
More posts featuring Zuzana Santamaria.